person

Anne-Lise P.

Country
France
Department
Neuropédiatrie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
1
Sites with multiple studies

Has run more than one trial at 1 of 21 partner sites.

Specializations

Neurological Disorders

The investigator specializes in treating rare demyelinating disorders, with particular focus on myelin oligodendrocytes glycoprotein antibody associated diseases (MOGAD). Their research explores innovative therapeutic approaches for acute demyelinating syndromes in pediatric patients.

  • Pediatric Autoimmune Disorders
  • Demyelinating Diseases
  • Antibody-Mediated Conditions

Their expertise extends to immunotherapy interventions, including the application of azathioprine and rituximab treatments in pediatric neurological conditions.

Rare Genetic Disorders

The investigator focuses on therapeutic interventions for Late Metachromatic Leukodystrophy (MLD), a rare genetic disorder affecting the nervous system. Their work involves evaluating enzyme replacement therapies administered through intrathecal delivery methods.

  • Lysosomal Storage Disorders
  • Enzyme Replacement Therapy
  • Pediatric Neurodegenerative Conditions

The research encompasses long-term safety assessments and therapeutic efficacy in pediatric patients with metabolic disorders affecting the central nervous system.

Pediatric Therapeutics

The investigator specializes in developing treatment strategies for complex pediatric neurological conditions. Their work focuses on innovative therapeutic approaches for children with rare neurological and metabolic disorders.

  • Pediatric Clinical Trials
  • Novel Treatment Approaches
  • Long-term Safety Studies

Their expertise encompasses both immediate and delayed treatment protocols, with particular attention to safety and efficacy in young patients.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.